Recruiting ALS Studies in Fairway
A Study of Ranolazine in ALS
The purpose of this study is to evaluate safety, effect on cramps, function and quality of life of ranolazine versus placebo for the treatment of ALS....
Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)
This is the study of AMT-162 in Participants with SOD1-ALS and is designed to evaluate the safety, tolerability, and exploratory efficacy of intrathecally administered gene therapy AMT-162. AMT-162-00...
About ALS Clinical Trials in Fairway
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects motor neurons controlling voluntary muscle movement. Also known as Lou Gehrig's disease, it leads to increasing paralysis. Research is actively pursuing disease-modifying treatments and gene therapies.
There are currently 2 als clinical trials recruiting participants in Fairway, KANSAS. These studies are seeking a combined 92 participants. Research is being sponsored by Swathy Chandrashekhar, MBBS, UniQure Biopharma B.V.. Clinical trial participation is free and participants receive study-related medical care at no cost.
ALS Clinical Trials in Fairway — FAQ
Are there als clinical trials in Fairway?
Yes, there are 2 als clinical trials currently recruiting in Fairway, KANSAS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Fairway?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fairway research site will contact you about next steps.
Are clinical trials in Fairway free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fairway studies also compensate for your time and travel.
What als treatments are being tested?
The 2 active trials in Fairway are testing new therapies including novel drugs, biologics, and treatment approaches for als.
Data updated March 2, 2026 from ClinicalTrials.gov